Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$42.57 USD

42.57
740,451

-0.06 (-0.14%)

Updated Sep 27, 2024 04:00 PM ET

After-Market: $42.57 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (164 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Globus Medical (GMED) Stock Fell on Preliminary Q1 Sales Results

Globus Medical's (GMED) Q1 preliminary sales results reflect an increase in procedural volumes along with growth in Enabling Technologies business.

AMN Healthcare Services (AMN) Stock Moves -0.87%: What You Should Know

In the latest trading session, AMN Healthcare Services (AMN) closed at $108.82, marking a -0.87% move from the previous day.

Here is Why Growth Investors Should Buy AMN Healthcare (AMN) Now

AMN Healthcare (AMN) possesses solid growth attributes, which could help it handily outperform the market.

Here's Why You Should Retain Baxter (BAX) Stock For Now

Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio and regulatory clearances.

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, contraction in gross margin is a woe.

Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio

Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.

Here's Why You Should Hold on to Illumina (ILMN) Stock For Now

Investors are optimistic about Illumina's (ILMN) strategic collaborations and strong international sales.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.

Merit Medical's (MMSI) Latest Launch to Boost Patient Outcome

Merit Medical's (MMSI) latest well-designed tray is expected to simplify the thoracostomy procedure and reduce treatment time, especially in critical situations.

Here's Why You Should Retain Bio-Rad (BIO) Stock For Now

Investors are optimistic about Bio-Rad (BIO) owing to a recovery in most of its key global markets as well as an uptick in demand for COVID-related products.

Patterson Companies (PDCO) Moves Up 12.5%: What's Driving It?

Investors are optimistic about Patterson Companies' (PDCO) robust segmental performance and strong prospects in the dental space.

Thermo Fisher (TMO) Debuts GMP-Manufactured Cas9 Protein

Thermo Fisher's (TMO) Gibco CTS TrueCut Cas9 Protein to support genome editing for research and manufacturing applications.

Here's Why You Should Hold on to CONMED (CNMD) Stock Now

CONMED (CNMD) continues to gain momentum from a solid product portfolio and strong General Surgery business. However, data security threats linger.

McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Catalent's (CTLT) Latest Manufacturing Suites to Boost Capacity

Catalent's (CTLT) latest site expansion is expected to significantly boost its business.

Henry Schein (HSIC) Stock Moves Up 20.6%: What's Driving It?

Henry Schein's (HSIC) stock rallied on strong fourth-quarter performance and bullish 2022 EPS guidance.

Here's Why You Should Hold on to Insulet (PODD) Stock For Now

Investors are optimistic about Insulet (PODD) on robust uptake of the Omnipod system and bullish guidance.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.

AMN Healthcare Services (AMN) Stock Moves -1.11%: What You Should Know

AMN Healthcare Services (AMN) closed the most recent trading day at $104, moving -1.11% from the previous trading session.

DexCom (DXCM) G6 CGM System Now Available to TRICARE Members

The availability of DexCom's (DXCM) G6 CGM System to diabetic TRICARE military members is expected to enable them to make better real-time decisions about their health.

Fresenius Medical (FMS) Launches Campaign to Boost Kidney Care

Fresenius Medical's (FMS) My Reason campaign will help scientists understand genetic variations in patients with chronic kidney disease in a better way.

Here's Why You Should Retain Phibro (PAHC) Stock For Now

Investors are optimistic about Phibro (PAHC) owing to the robust performances by its Animal Health and Mineral Health segments.

Integer Holdings' (ITGR) Latest Buyout to Expand Its Footprint

Integer Holdings' (ITGR) buyout of Aran Biomedical is set to expand its presence in high-growth markets as well as enhance its product offerings.

Masimo's (MASI) Sound United Buyout to Boost Product Portfolio

Masimo's (MASI) completion of Sound United's buyout to help enhance the former's extended portfolio of hospital and home medical technology solutions.

Illumina (ILMN) Launches Genomic Solution Hub in Brazil

Illumina's (ILMN) customers and partners in Brazil currently span basic research, applied markets to clinical labs and healthcare institutions.